Annual Report and AGM Notice

RNS Number : 7905J
Alliance Pharma PLC
10 April 2015
 



For Immediate Release

                                                  10 April 2015

 

 

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

 

Annual Report and AGM Notice

                                                                                   

Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, is pleased to announce that its 2014 Annual Report and Accounts and Notice of Annual General Meeting, which will be held on 27 May 2015, are now available on the Company's website at www.alliancepharma.co.uk.

 

Printed copies of both documents will be posted to shareholders shortly and may also be requested by email at ir@alliancepharma.co.uk.

 

 

For further information:

 

Alliance Pharma plc

+ 44 (0) 1249 466966

John Dawson, Chief Executive


Richard Wright, Finance Director


www.alliancepharma.co.uk


Buchanan

+ 44 (0) 20 7466 5000

Mark Court / Sophie Cowles / Jane Glover




Numis Securities Limited

+ 44 (0) 20 7260 1000

Nominated Adviser: Michael Meade / Freddie Barnfield


Corporate Broking: David Poutney


 

 

Notes to editors:

 

About Alliance

Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products and continues to explore opportunities to expand the range.

 

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDMGGDKLLGKZM
UK 100